To demonstrate that the CEA CAR-T cells overexpressing Bcl-xL have the ability in inducing CEA-specific T cell persistence in a physiologically and clinically relevant setting, we used a murine model of colorectal cancer (Supplementary Data 2). Here, BCL2L1 is linked to colorectal cancer.